A new study has found that biologic class and treatment sequencing influences psoriatic arthritis risk in patients with ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated ...

Celebrities may have glam squads and access to the best doctors and treatments in the world — and yet even they have skin ...

Adding a dual GLP-1/GIP receptor agonist to the psoriasis drug ixekizumab (Taltz) significantly improved outcomes in adults ...

New EULAR recommendations for the management of rheumatoid arthritis stress that disease-modifying antirheumatic drugs should ...

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.

RA can affect more than your joints—here are the symptoms doctors say are often overlooked.